These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Zoledronic acid enhances the effect of radiotherapy for bone metastases from renal cell carcinomas: more than a 24-month median follow-up. Takeda N, Isu K, Hiraga H, Shinohara N, Minami A, Kamata H. J Orthop Sci; 2012 Nov; 17(6):770-4. PubMed ID: 23053582 [Abstract] [Full Text] [Related]
15. A case of bone, lung, pleural and liver metastases from renal cell carcinoma which responded remarkably well to zoledronic acid monotherapy. Miwa S, Mizokami A, Konaka H, Izumi K, Nohara T, Namiki M. Jpn J Clin Oncol; 2009 Nov 02; 39(11):745-50. PubMed ID: 19808839 [Abstract] [Full Text] [Related]